Oncology & Cancer

Immunotherapy delays disease progression of high-grade meningiomas

Meningiomas, tumors of the membranes (meninges) surrounding the brain and spinal cord, are the most common tumors of the central nervous system. Although most meningiomas are low grade and cause few or no symptoms, a subset, ...

Oncology & Cancer

Immunotherapy drug bolsters head and neck cancer treatment

A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.

Diseases, Conditions, Syndromes

The omicron surge: Is the worst almost over?

While COVID-19 cases and hospitalizations are expected to remain high in Chicago and across the country in the coming weeks, experts at RUSH predict that the worst of the omicron surge may be behind us.

page 6 from 17